Huaxia Eye Hospital Group Co.,Ltd. (SHE:301267)

China flag China · Delayed Price · Currency is CNY
19.04
-0.05 (-0.26%)
At close: Jan 21, 2026
6.91%
Market Cap15.87B
Revenue (ttm)4.12B
Net Income (ttm)441.43M
Shares Out832.47M
EPS (ttm)0.53
PE Ratio36.04
Forward PE34.04
Dividend0.22 (1.16%)
Ex-Dividend DateDec 22, 2025
Volume4,537,222
Average Volume5,144,200
Open19.05
Previous Close19.09
Day's Range18.98 - 19.23
52-Week Range17.43 - 23.17
Beta0.52
RSI55.81
Earnings DateApr 28, 2026

About Huaxia Eye Hospital Group

Huaxia Eye Hospital Group Co.,Ltd. operates an ophthalmic medical chain in China and internationally. The company provides general ophthalmology diagnosis and treatment services for patients with ophthalmic diseases; and myopia prevention and intervention work to the public. It offers services in the areas of cataract, refraction, fundus, strabismus and amblyopia, pediatric ophthalmology, ocular surface, glaucoma, orbital and ocular tumors, and ocular trauma. The company was founded in 1997 and is based in Xiamen, China. [Read more]

Sector Healthcare
Founded 1997
Employees 7,883
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301267
Full Company Profile

Financial Performance

In 2024, Huaxia Eye Hospital Group's revenue was 4.03 billion, an increase of 0.35% compared to the previous year's 4.01 billion. Earnings were 428.64 million, a decrease of -35.63%.

Financial Statements